Wordt geladen...
Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
BACKGROUND: Metastatic pancreatic ductal adenocarcinoma (mPDAC) bears a dismal prognosis due to the limited activity of systemic chemotherapy. In our platform for precision medicine, we aim to offer molecular-guided treatments to patients without further standard therapy options. METHODS: In this si...
Bewaard in:
| Gepubliceerd in: | Ther Adv Med Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357054/ https://ncbi.nlm.nih.gov/pubmed/32699558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920938611 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|